MIT Center for M-CELS Member Scott Manalis developed a new way to determine whether individual patients will respond to a specific cancer drug or not

graphic of cell mass measuring device
Device used for testing drugs

Professor Scott Manalis and Keith Ligon of the Dana-Farber Cancer Institute have published a paper in Cell Reports, out today.

See the full story on MIT News.

Leave a comment